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Conditional gene targeting has been extensively used for in vivo
analysis of gene function in adipocyte cell biology but often with
debate over the tissue speciﬁcity and the efﬁcacy of inactivation.
To directly compare the speciﬁcity and efﬁcacy of different Cre
lines in mediating adipocyte speciﬁc recombination, transgenic
Cre lines driven by the adipocyte protein 2 (aP2) and adiponectin
(Adipoq) gene promoters, as well as a tamoxifen-inducible Cre
driven by the aP2 gene promoter (iaP2), were bred to the
Rosa26R (R26R) reporter. All three Cre lines demonstrated re-
combination in the brown and white fat pads. Using different
ﬂoxed loci, the individual Cre lines displayed a range of efﬁcacy
to Cre-mediated recombination that ranged from no observable
recombination to complete recombination within the fat. The
Adipoq-Cre exhibited no observable recombination in any other
tissues examined, whereas both aP2-Cre lines resulted in recom-
bination in endothelial cells of the heart and nonendothelial, non-
myocyte cells in the skeletal muscle. In addition, the aP2-Cre line
can lead to germline recombination of ﬂoxed alleles in ;2% of
spermatozoa. Thus, different “adipocyte-speciﬁc” Cre lines dis-
play different degrees of efﬁciency and speciﬁcity, illustrating
important differences that must be taken into account in their
use for studying adipose biology. Diabetes 62:864–874, 2013
Adipose tissue plays an important role in metab-olism through its storage and release of trigly-cerides, peptide hormones (adipokines) andother proteins, and in the case of brown fat, for
its role in thermogenesis (1). Excess adipose tissue (i.e.,
obesity) is a risk factor for numerous comorbidities, in-
cluding type 2 diabetes, coronary heart disease, hyper-
tension, hepatosteatosis, and even cancer (2).
Analysis of adipocyte function in vivo has beneﬁted
from the development of mouse lines that use the Cre/
LoxP site-speciﬁc recombination system to inactivate
speciﬁc genes in fat (3). The use of such targeting systems
has allowed researchers to clarify the relative contribution
of the adipose tissue in many metabolic phenotypes and
circumvent lethality that might be associated with in-
activation of genes at the whole-body level. Several dif-
ferent Cre transgenes have been used for this purpose. The
most common use the promoter of the mouse adipocyte
protein-2 (aP2) gene, which encodes fatty acid-binding
protein-4 (Fabp4). A 5.4-kb piece of the aP2 promoter/
enhancer has been shown to be sufﬁcient to direct ex-
pression in adipocytes (4,5). At least three independent
laboratories have developed aP2-Cre transgenic mice. The
ﬁrst aP2-Cre line was created by Kleanthis Xanthopoulos
(6); subsequently, the aP2-CreBI line was created by
Barbara Kahn (Beth Israel, Boston, MA) (7), and the aP2-
CreSI was created by Ronald Evans (Salk Institute, San
Diego, CA) (8). In addition, the aP2 promoter has been
used by the Chambon laboratory (Institut de Génétique
et Biologie Moléculaire et Cellulaire, Paris, France) to
drive the expression of a tamoxifen-inducible Cre
transgene (aP2-CreERT2), which is only able to recom-
bine ﬂoxed alleles in the presence of 4-hydroxytamoxifen
(4-OHT) (9,10).
Although aP2/Fabp4 was originally identiﬁed as an adi-
pocyte-speciﬁc protein, recent studies have shown that
Fabp4 is also expressed in other cell types (11), including
macrophages (12–14), the lymphatic system (15), and dur-
ing embryogenesis (16). To circumvent the possible side
effects of gene deletion of the aP2-Cre in tissues other than
adipocytes, two laboratories have developed adiponectin-
Cre transgenic mice (Adipoq-Cre), with expression of a Cre
recombinase driven by the promoter/regulatory regions of
the mouse adiponectin locus using a bacterial artiﬁcial
chromosome (BAC) transgene (17) or by a 5.4-kB pro-
moter fragment (18).
In the current study, we have directly compared the
speciﬁcity and efﬁcacy of three mouse transgenic Cre
lines—the aP2-CreBI, aP2-CreERT2, and Adipoq-Cre BAC
transgenic mouse lines—in mediating adipocyte-speciﬁc
recombination using a number of different ﬂoxed alleles
as well as by breeding these mice to the LacZ-Gt(ROSA)
26Sortm1Sor (termed R26R-lacZ) reporter mouse, in which
Cre-mediated recombination irreversibly activates a lacZ
reporter gene (19). We ﬁnd that all of the Cre lines induce
recombination in the adipose tissue. In addition, the aP2-
CreBI and aP2-CreERT2 lines both induce recombination
in the capillary endothelium in the heart and in inter-
myoﬁbrillar cells in the skeletal muscle, but not in mac-
rophages in adipose tissue. Interestingly, we ﬁnd that
different ﬂoxed gene loci display differential sensitivity to
Cre-mediated recombination and that different adipose
depots recombine to different extents. The aP2-CreBI can
also lead to germline recombination of ﬂoxed alleles.
These results illustrate the differences between “adipose-
speciﬁc” Cre lines and caveats in their use that are critical
for interpretation of research using these models.
RESEARCH DESIGN AND METHODS
Animals and diets. aP2-CreBI and aP2-CreERT2 mice were maintained
on a C57BL/6 background. Adipoq-Cre mice had also been backcrossed to
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C57BL/6; however, single nucleotide polymorphism panel analysis revealed
that these mice, although largely C57BL/6, still have markers of a mixed ge-
netic background (http://jaxmice.jax.org/strain/010803.html).
The Cre mice were bred to Gt(ROSA)26Sortm1Sor obtained from Jackson
Laboratories on the C57BL/6 background. Mice with ﬂoxed alleles of insulin
receptor (IR), Hif1b, Igf1r, Dicer, Shox2, and Tfam have previously been
described (20–25), as have the generation of fat-speciﬁc knockouts of Glut4,
peroxisome proliferator-activated receptor-g (Pparg), IR, Hif1b, Tfam, and
IR/Igf1r with the aP2-Cre mouse (7,26–30). The generation of fat-speciﬁc
knockouts of PTP1B, Ppar-g coactivator-1a (Pgc1a), and SH2-containing
protein tyrosine phosphatase-2 (Shp2) with the Adipoq-Cre have also been
described (31–33). All mice were housed in a mouse facility on a 12-h light/
dark cycle in a temperature-controlled room with ad libitum access to water
and food.
For tamoxifen treatment of aP2-CreERT2, tamoxifen was dissolved in
a solution of 10% ethanol in sunﬂower seed oil at a concentration of 50 mg/mL.
Mice were gavaged with this solution (100 mL) daily for 5 days and killed 2
weeks later. Daily gavage with 4-hydroxytamoxifen (4-OHT) led to a slight
decrease (;3 g) in the body weight of mice. Similar recombination efﬁcien-
cies, without effects on body weight, were observed after three cycles of ga-
vage every other day and killing the animals 2 weeks after the last dose.
Longer treatment protocols did not increase deletion efﬁcacy. Other treatment
methods led to undesirable complications. Intraperitoneal injection 4-OHT led
to excess oil unabsorbed in the abdomen and mild peritonitis, and sub-
cutaneous injection led to the formation of granulomas at the site of injection
(data not shown).
Animal care and study protocols were approved by the Joslin Diabetes
Center Animal Care Committee and were in accordance with the National
Institutes of Health guidelines.
Detection of b-galactosidase activity. Fat pads were whole-mount stained.
Other tissues were cut into 10-mm cryosections and stained for b-galactosidase
activity, as previously described (34).
Macrophage isolation. Peritoneal macrophages were collected by injecting
5 mL ice-cold PBS supplemented with 1% BSA into the peritoneal cavity and
collecting the resultant cell suspension. Fat resident and recruited macro-
phages were collected by excising andmincing epididymal white adipose tissue
into 5 mL with Liberase Thermolysin Medium (21.5 mg/mL, Dicer Roche) and
incubated at 37°C for 45 min with shaking. Larger particles were removed
using 250-mm nylon sieves and the ﬁltrates were centrifuged at 300g for 5 min
to separate ﬂoating adipocytes from the stromal-vascular fraction (SVF) pel-
lets. SVF pellets containing macrophages and cell suspensions containing
peritoneal macrophages were treated with 100 mL ACK lysis buffer (Lonza)
for 5 min at room temperature, and washed with PBS. Macrophages were
stained in 100 mL staining buffer (PBS containing 1% BSA with F4/80-APC;
E-Bioscience). Cells were again washed, ﬁltered through a 40-mm mesh, and
F4/80-positive cells were sorted by FACSAria (BD Biosciences).
Immunoﬂuorescence and immunohistochemistry. Colocalization of Fabp4
and CD31 was assessed in the fat by whole-mount immunoﬂuorescence
using hamster anti-mouse CD31monoclonal antibodies (1:500; BDBiosciences)
and rabbit anti-Fabp4 polyclonal antibodies (1:200; Cell Signaling), anti-
hamster-FITC (1:1,000; BD Biosciences), and goat anti-rabbit Alexa 564
(1:1,000; Invitrogen). Photographs were generated using an inverted confocal
microscope. Colocalization in heart and muscle was assessed using cryo-
sections with the same antibodies. F4/80 localization was assessed using rat
anti-F4/80 (1:100; Abcam) and goat anti-rat Alexa 488 (1:1000; Invitrogen).
Quantiﬁcation of b-galactosidase activity. Total protein lysates were
made by homogenizing tissue in M-PER Reagent (Pierce). Five hundred
micrograms of concentrated protein lysate was added to 100 mL b-galactosidase
FIG. 1. Analysis of Cre-induced recombination in the aP2-CreBI R26R-lacZ Mice. A: Whole-mount X-gal staining of fat pads from the aP2-CreBI
R26R-lacZ mouse. Brown, subcutaneous, and perigonadal adipose tissue from 3-month-old chow-fed aP2-CreBI R26R-lacZ (n = 4) after overnight
incubation in X-gal staining solution (scale bar = 1 cm). B: Representative sections from aP2-CreBI R26R-lacZ X-gal stained fat pads. Fat pads from
panel A were ﬁxed in Bouin’s ﬁxative and embedded in parafﬁn; 8-mm sections were hematoxylin stained. Representative images are shown. C:
Representative sections from aP2-CreBI R26R-lacZ tissues stained with X-gal. Lung, heart, testis, and muscle from 3-month-old chow-fed aP2-CreBI
R26R-lacZ (n = 4) were embedded in optimal cutting temperature medium; 10-mm sections were X-gal stained, and counterstained with nuclear fast
red. Representative images are shown.
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staining solution (34) and incubated overnight. Absorbance was measured at
635 nmol/L.
Assessment of germline recombination. DNA from tail biopsies was
extracted and subjected to PCR. In addition to primers that discriminate be-
tween ﬂoxed and wild-type alleles, an additional primer to assess the presence
of recombined ﬂoxed alleles (D allele) was added. For the IR locus: forward
primer 59-ctgaatagctgagaccacag-39; reverse primer 59- gatgtgcaccccatgtctg-39;
delta primer 59-tctatcaaccgtgcctagag-39. For the Tfam locus: forward primer
59-ctgccttcctctagcccggg-39; reverse primer 59-gtaacagcagacaacttgtg-39; delta
primer 59-ctctgaagcacatggtca at-39.
RESULTS
aP2-CreBI recombination in adipose tissue, heart,
skeletal muscle, and testis. aP2-CreBI mice were bred
with R26R-lacZ reporter mice to visualize the tissues in
which Cre-mediated recombination occurred. X-gal stain-
ing of fat pads of 3-month-old mice, revealed strong recom-
bination in the brown adipose tissue (BAT), subcutaneous
fat, and perigonadal fat (Fig. 1A). Sections from these fat
pads show extensive lacZ staining in adipocytes but no
staining in large blood vessels in the subcutaneous fat,
as indicated by the arrows (Fig. 1B). This staining was
relatively fat-speciﬁc, because no staining, or only scat-
tered rare blue nuclei, were observed in other tissues, in-
cluding the liver, kidney, brain, thymus, adrenal, pancreas,
spleen, uterus, ovary, skin, and salivary gland (Supple-
mentary Fig. 1). However, X-gal staining was observed in
the heart, lung, and selected nuclei in skeletal muscle
(Fig. 1C). Strikingly, strong recombination was also ob-
served in the developing spermatogonium of ;2% of the
seminiferous tubules but was completely absent in the
other 98% (Fig. 1C, lower left), suggesting clonal germ line
recombination occurs during spermatogenesis.
Localization of endogenous Fabp4 expression. When
crossed with R26R-lacZ reporter mice, aP2-CreBI mice
show recombination limited mostly to the fat pads, but
also in the heart and muscle. Quantitative (q)PCR analysis
of Fabp4 and Adiponectin mRNA across a wide panel of
tissues revealed that both are primarily expressed in fat,
with very low expression levels in other tissues (Supple-
mentary Fig, 2). To better deﬁne these additional cell types
exhibiting recombination in the aP2-CreBI mice, we lo-
calized endogenous aP2/Fabp4 in mouse adipose tissue,
FIG. 2. Endogenous expression of Fabp4 in wild-type mice. A: Double immunoﬂuorescence for the endothelial cell markers CD31 and Fabp4 in the
perigonadal fat, heart, and muscle of 2-month-old C57BL/6 male mice. Perigonadal fat pads were whole-mount stained and representative com-
posite (original magniﬁcation 310) pictures created from Z-stacks of several images taken by confocal microscopy are shown (scale bar = 50 mm).
Images for double immunoﬂuorescence for CD31 and Fabp4 in heart and muscle are representative original magniﬁcation 320 images (scale bar =
200 mm). B: Double immunoﬂuorescence for the macrophage marker, F4/80 and Fabp4 in the perigonadal fat of wild-type mice. Representative
images (original magniﬁcation 340) of double immunoﬂuorescence for F4/80 and Fabp4 in the perigonadal fat of 12-month-old wild-type C57BL/6
mice (scale bar = 50 mm). C: qPCR analysis of Fabp4 from sorted F4/80-positive cells from the peritoneal cavity and adipose tissue and whole
adipose tissue of male mice (n = 6) after 12 weeks of a high-fat diet (started at age 6 weeks). Data are normalized to the expression of TATA
binding protein (Tbp) and are shown as mean 6 SEM.
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myocardium, and skeletal muscle by double immunoﬂuo-
rescence with anti-Fabp4 and anti-CD31, which stains en-
dothelial cells, or an anti-F4/80 antibody, which marks
macrophages (Fig. 2A). Confocal images of the whole-
mount stained perigonadal adipose tissue demonstrated
only very slight colocalization of CD31 and Fabp4 (Fig. 2A).
No colocalization was observed between anti-F4/80 and
anti-Fabp4 antibodies in perigonadal fat (Fig. 2B), dem-
onstrating that Fabp4 is not highly expressed in macrophages
or endothelial cells. The immunoﬂuorescence demon-
strates that Fabp4 expression is limited almost exclusively
to adipocytes. Furthermore, qPCR analysis of sorted F4/80
positive macrophages from the peritoneal ﬂuid and peri-
gonadal adipose tissue shows that levels of Fabp4 in
macrophages are several thousandfold lower than those
found in whole adipose tissue (Fig. 2C).
Colocalization of CD31 and Fabp4 was not observed in
skeletal muscle; however, in the heart, Fabp4 did coloc-
alize with CD31 staining in small capillaries. Interestingly,
large CD31-positive blood vessels in the heart did not stain
positively for Fabp4, indicating that endogenous Fabp4 is
expressed only in a speciﬁc subset of endothelial cells
(Fig. 2A).
aP2-CreERT2 recombination in adipose tissue, heart,
muscle, and salivary gland. The 4-OHT–inducible Cre
driven by the aP2 promoter (aP2-CreERT2) allows for
temporal control of recombination (9). In the absence of
4-OHT, no X-gal staining was observed in any tissue in
male or female mice (Fig. 3A and C, Supplementary Fig. 3).
Upon oral 4-OHT treatment, X-gal staining was observed in
the subcutaneous and perigonadal fat pads (Fig. 3A).
Sections through these fat pads show limited X-gal staining
(Fig. 3B). In agreement with observations from the
aP2-CreBI, recombination was observed in capillaries of
the myocardium and in interﬁbrillar cells in skeletal mus-
cle (Fig. 3C). Unlike the aP2-CreBI, recombination was also
observed in the epithelium of the salivary gland after
4-OHT exposure (Fig. 3C). No staining was observed in
any other tissue after 4-OHT treatment (Supplementary
Fig. 4).
Adipoq-Cre recombination in adipose tissue. Whole-
mount X-gal staining of fat pads of 6-week-old Adipoq-Cre
mice crossed to R26R-lacZ reporter mice revealed strong
recombination in the brown, subcutaneous, and peri-
gonadal fat (Fig. 4A). Upon sectioning, robust lacZ staining
can be seen in adipocytes from all depots, with no staining
in the blood vessels of the subcutaneous fat (Fig. 4B,
arrows). The recombination from the Adipoq-Cre mice was
fat-speciﬁc, because absolutely no staining was observed
in other tissues, including the liver, kidney, brain, thymus,
adrenal, pancreas, spleen, lung, testis, salivary gland, ovary,
or uterus (Supplementary Fig. 5). In contrast to the aP2-
CreBI lines, no expression was observed in the myocar-
dium or skeletal muscle; however, some recombination
was observed in dermal adipocytes of the skin (Fig. 4C).
Quantiﬁcation of Cre expression and recombination
of the aP2-CreBI, aP2-CreERT2, and Adipoq-Cre lines.
Cre mRNA levels from subcutaneous, perigonadal, and
brown fat, as well as muscle, heart, and liver, were ana-
lyzed in aP2-CreBI, aP2-CreERT2, and Adipoq-Cre mice
using qPCR. In all three fat pads, the aP2-CreBI exhibited
the highest Cre expression at the mRNA level, with ex-
pression also observed in the heart and muscle (Fig. 5A).
The aP2-CreERT2 expressed low levels of Cre mRNA in
the fat pads and also exhibited expression in the heart
and liver. Conversely, in the Adipoq-Cre mice, Cre mRNA
FIG. 3. Analysis of Cre-induced Recombination in the aP2-CreERT2 R26R-lacZ mice. A: Whole-mount X-gal staining of fat pads from the aP2-
CreERT2 R26R-lacZ mouse. Subcutaneous and perigonadal adipose tissue from 4 month old chow-fed aP2-CreERT2 R26R-lacZ (n = 3 per group)
treated with vehicle or tamoxifen after overnight incubation in X-gal staining solution. B: Representative sections from aP2-CreERT2 R26R-lacZ
X-gal-stained fat pads. Fat pads from Fig. 2A were ﬁxed in Bouin’s ﬁxative, embedded in parafﬁn, and 8-mm sections were stained with hematoxylin.
Representative images are shown. C: Representative sections from aP2-CreERT2 R26R-lacZ tissues stained with X-gal. Heart, skeletal muscle, and
salivary from 4-month-old chow-fed aP2-CreERT2 R26R-lacZ treated with vehicle or tamoxifen (n = 3) were embedded in optimal cutting tem-
perature medium, and 10-mm sections were X-gal stained and counterstained with nuclear fast red. Representative images are shown.
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expression was found exclusively in the fat pads, with no
detectable expression in heart, muscle, or liver. Assess-
ment of Cre protein level by Western blot showed that in
the subcutaneous and brown fat, Cre protein levels were
high both in the aP2-CreBI and Adipoq-Cre, with only min-
imal expression in the aP2-CreERT2 (Fig. 5B).
Whole-mount b-galactosidase staining demonstrated
that the aP2-CreBI and Adipoq-Cre mouse lines effectively
recombine the Rosa locus. However, to quantify this re-
combination, a colorimetric assay was developed using
b-galactosidase activity as a readout for the degree of re-
combination of tissues from aP2-CreBI and Adipoq-Cre lines
crossed to the R26R-lacZ reporter mice. Lysates fromR26R-
lacZ reporter mice alone were used to establish baseline
readings. b-Galactosidase activity was found in all fat pads
of aP2-CreBI and Adipoq-Cre mice. aP2-CreBI Cre showed a
greater extent of recombination in BAT,whereasAdipoq-Cre
showed slightly greater recombination in the subcutaneous
fat and perigonadal fat. A small amount of b-galactosidase
activity over background was observed in the aP2-CreBI in
the heart and muscle, but not in liver (Fig. 5C).
Recombination efﬁciency of the aP2-CreBI is allele-
and age-dependent. The aP2-CreBI mouse has been
crossed to multiple lines harboring different ﬂoxed alleles
to generate fat-speciﬁc knockout mouse models. In most
cases, recombination was adipose-speciﬁc as determined
by qPCR analysis, which showed no signiﬁcant recom-
bination in the liver, heart, or brain with any of the ﬂoxed
alleles. Interestingly, in some cohorts, up to a 60% reduction
of IR mRNA was observed in the skeletal muscle of fat-
speciﬁc insulin receptor knockout (FIRKO) animals, but
this was not observed with any of the other genes (Table 1).
There was also differential recombination efﬁciency
across different alleles and in different fat pads. This may
represent differences in efﬁcacy of recombination or dif-
ferential expression of the targeted locus in different cells
within the fat pad. qPCR analysis showed reductions of
Hif1b RNA of 63, 68, and 89% in whole fat perigonadal,
subcutaneous, and brown fat compared with ﬂoxed con-
trols. In the white fat depots, the lower recombination rate
was at least partly due to the presence of Hif1b in other
cells of the fat pad. Thus, qPCR analysis of isolated adi-
pocytes revealed 83 and 86% reduction of Hif1b mRNA in
perigonadal and subcutaneous adipocytes, respectively.
There was also modest reduction of Hif1b in the SVF of
the perigonadal and subcutaneous fat of 27 and 40%, sug-
gesting recombination in preadipocytes or early adipo-
cytes present in the fraction.
Recombination of Shox2 in aP2-CreBI mice resulted in
reductions of Shox2 mRNA of 48, 58, and 81% in peri-
gonadal, subcutaneous, and brown fat compared with
ﬂoxed controls, respectively. Recombination of the Pparg
locus was also very efﬁcient with the aP2-CreBI mice. Fat-
speciﬁc ablation of Pparg with the aP2-CreBI led to a
complete absence of Pparg mRNA in brown fat. In the
white fat pads, mRNA Pparg levels were reduced more
than 90% in the subcutaneous white fat and completely
ablated in the perigonadal fat pad.
FIG. 4. Analysis of Cre-induced recombination in the Adipoq-Cre R26R-lacZ mice. A: Whole-mount X-gal staining of fat pads from the Adipoq-Cre
R26R-lacZ mouse. Brown, subcutaneous, and perigonadal adipose tissue from 6-week-old chow-fed R26R-lacZ only or Adipoq-Cre R26R-lacZ (n = 4
per group) after overnight incubation in X-gal staining solution. B: Representative sections from Adipoq-Cre R26R-lacZ fat pads stained with X-gal.
Fat pads from Fig. 2A were ﬁxed in Bouin’s ﬁxative, embedded in parafﬁn, and 8-mm sections were stained with hematoxylin. Representative
images are shown. Arrows indicate negative staining in the vasculature. C: Representative sections from Adipoq-Cre R26R-lacZ tissues stained
with X-gal. Muscle, heart, and skin from 3-month-old chow-fed Adipoq-Cre R26R-lacZ were embedded in optimal cutting temperature compound,
and 10-mm sections were stained with X-gal and counterstained with nuclear fast red. Blue staining in skin section is due to the presence of dermal
adipocytes. Representative images are shown.
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Conversely, using the aP2-CreBI line and mice with
a ﬂoxed Tfam (mitochondrial transcription factor A) al-
lele, there was a 67% reduction at the mRNA level in the
brown fat, but no signiﬁcant reduction of Tfam mRNA was
observed in the perigonadal or subcutaneous fat pads.
When the fat pads were digested, there was a signiﬁcant
54% reduction of TfammRNA in the isolated subcutaneous
adipocytes, but no reduction in isolated perigonadal adi-
pocytes, demonstrating a major depot-speciﬁc difference
in recombination. No differences in Tfam mRNA levels
were observed in the isolated SVF of these mice.
In contrast to the other gene knockouts presented here,
which were born at expected Mendelian ratios, attempts to
ablate Dicer using the aP2-CreBI resulted in early postnatal
lethality precluding further analysis. This early postnatal
lethal phenotype was also observed by another group that
FIG. 5. Quantiﬁcation of Cre expression and recombination of the aP2-
CreBI, aP2-CreERT2, and Adipoq-Cre lines. A: Quantiﬁcation of Cre
mRNA expression of tissues from aP2-CreBI, aP2-CreERT2, and Adipoq-
Cre lines. qPCR analysis of subcutaneous (SC) fat, perigonadal (PG)
fat, brown fat, muscle, heart, and liver was performed using tissues
from 3- to 5-month-old aP2-CreBI (n = 4), aP2-CreERT2 (n = 4), and
Adipoq-Cre (n = 3) mice. All animals were maintained on a chow diet,
and data are represented as mean 6 SEM. B: Quantiﬁcation of Cre
protein expression of adipose tissues from aP2-CreBI, aP2-CreERT2,
and Adipoq-Cre mice. Western blot analysis of subcutaneous, peri-
gonadal, and brown fat from 3- to 5-month-old aP2-CreBI, aP2-CreERT2,
and Adipoq-Cre mice. All animals were maintained on a chow diet. C:
Quantiﬁcation of recombination in tissues from aP2-CreBI and Adipoq-
Cre mice. A colorimetric assay for b-galactosidase activity was per-
formed on subcutaneous fat, perigonadal fat, brown fat, muscle, heart,
and liver from control R26R-lacZ mice (n = 3), aP2-CreBI R26R-lacZ (n =
3), and Adipoq-Cre R26R-lacZ (n = 2) mice. All animals were 4 to 6
months old and maintained on a chow diet. Data are represented
mean 6 SEM.
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used the alternate aP2-CreSI (35) but was not observed
with the Adipoq-Cre (see below), indicating that this is due
to an inactivation of Dicer in some nonadipose tissue.
qPCR analysis also showed that IR at the mRNA level
was reduced by 79% in brown fat compared with ﬂoxed
controls in the fat pads of 2-month-old FIRKO animals but
was not signiﬁcantly reduced in the perigonadal and sub-
cutaneous fat. The recombination efﬁciency of the IR lo-
cus increased with age. By age 7 months, FIRKO animals
had reductions of IR mRNA of 66, 64, and 88% in peri-
gonadal, subcutaneous, and brown fat compared with
ﬂoxed controls. Similarly, in the double fat-speciﬁc knock-
out of insulin-like growth factor 1 receptor (IGF1R) and IR
(FIGIRKO) animals, recombination efﬁciency of the IR
locus was also improved in the perigonadal fat pad from
a 34% to a 54% reduction from 4 to 12 months but not in the
BAT or subcutaneous fat pad. No change in recombina-
tion efﬁciency of IGF1R was observed between 4- and
12-month-old animals. Thus, these data demonstrate re-
combination efﬁciency of the aP2-CreBI can vary across
both alleles and fat depots, and in certain contexts, the
recombination efﬁciency may also vary across the age of
the mice.
The varying degree of recombination efﬁciency, as
measured by mRNA message levels, was also observed
when protein concentrations were measured by Western
blotting. IR was not detectable at the protein level in
FIRKO fat pads and was 85–99% reduced in isolated adi-
pocytes (27). Likewise, Glut4 protein was signiﬁcantly re-
duced by 70–99% after recombination with the aP2-CreBI
(7). In agreement with the mRNA levels, in adipocytes
isolated from F-Hif1aKO and F-Hif1bKO mice, protein
levels of Hif1a and Hif1b are reduced ;90% by the aP2-
CreBI (36). Conversely, protein levels of PTP1B were only
reduced by ;50% in perigonadal fat pads of F-PTP1BKO
mice. These data further conﬁrm the allele-dependent re-
combination efﬁciency of the aP2-CreBI (Table 2).
Less efﬁcient recombination is observed with the
aP2-CreERT2. The aP2-CreERT2 has been used to ef-
fectively ablate genes such as the retinoid X receptor a
(Rxra) and Pparg in the adipose tissue (9,37). qPCR anal-
ysis showed aP2-CreERT2 reduced IR at the mRNA level
43, 33, and 33% in perigonadal, subcutaneous, and brown
fat tissue compared with ﬂoxed controls. Thus, recom-
bination of the IR locus was less efﬁcient in the inducible
knockout compared with the constitutive knockouts with
the aP2-CreBI (Table 1). The inducible fat-speciﬁc DicerKO
resulted in 54 and 49% decreases of Dicer mRNA in the
whole subcutaneous adipose tissue and BAT, with no
signiﬁcant difference in the perigonadal fat.
Efﬁcient recombination is achieved with the Adipoq-
Cre across numerous alleles. Owing to the poor re-
combination of the ﬂoxed Tfam and protein tyrosine
phosphatase 1B (PTP1B) alleles using the aP2-CreBI and
the early lethality it caused in ﬂoxed Dicer mice, we
crossed these mice to the Adiponectin-Cre mouse. All mice
lines were born at expected Mendelian ratio. As with the
aP2-Cre, signiﬁcant ablation of Tfam from whole fat pads
at the mRNA level was only observed with the Adipoq-Cre
in the brown fat, with a 73% reduction, but no signiﬁcant
reduction was observed in the perigonadal or sub-
cutaneous fat pads (Table 1). This reﬂects the high levels
of Tfam in nonadipocyte cells in the fat pad because iso-
lated adipocytes from perigonadal and subcutaneous fat
show signiﬁcant 75 and 49% reductions of Tfam mRNA
(Table 1). Western blot analysis of PTP-1B demonstratesTA
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efﬁcient ablation with the Adipoq-Cre in whole fat pads,
with reductions of 80–90%. In addition, PTP-1B protein
was undetectable in isolated adipocytes, but no change
was seen in the SVF of fat pads, the liver, or the muscle
(Table 2) (21). Efﬁcient ablation by the Adipoq-Cre was
also observed with Dicer, with reductions of Dicer mRNA
of 70, 61, and 81% in whole perigonadal, subcutaneous, and
brown fat compared with ﬂoxed controls. Similar reduc-
tions of Dicer mRNA was also observed in isolated adi-
pocytes, with 61 and 74% reduction of Dicer mRNA in
perigonadal and subcutaneous adipocytes, respectively,
with no signiﬁcant reductions in the SVFs of perigonadal
or subcutaneous fat. Efﬁcient ablation using the Adipoq-
Cre mouse has also been reported for the ﬂoxed alleles of
Pgc1a, and Shp2 (31,33). qPCR analysis showed Adipoq-
Cre reduced Pgc1a RNA more than 80% in the perigonadal
and subcutaneous fat, and more than 90% in brown fat. A
.90% reduction of Pgc1a RNA was found in perigonadal
adipocytes, with no changes in expression in the liver or
the muscle (Table 1). Similarly, no Pgc1a protein was
detectable even after chronic cold exposure (Table 2).
These data demonstrate speciﬁc and efﬁcient recombina-
tion of multiple alleles in adipocytes using the Adipoq-Cre
mice.
Incidence of germline deletion when using the aP2-
CreBI. Mice harboring Cre transgenes have been shown
to lead to occasional germline recombination of ﬂoxed
alleles (38). Because recombination is observed in testis of
aP2-CreBI mice, we tested our mice lines for evidence of
germline recombination. A PCR-based assessment of re-
combination was developed for each ﬂoxed allele and
performed with isolated tail DNA. For the IR locus, a
280-bp ampliﬁed product indicates a wild-type exon 4, a
320-bp product represents an intact ﬂoxed exon 4, and
a 220-bp product represents a ﬂoxed allele after Cre-
mediated recombination. The recombined allele is termed
the delta (D) allele (Fig. 6A). A similar PCR strategy was
developed for Tfam in which a 350-bp product indicates
a wild-type allele, a 420-bp product represents an intact
Tfam allele with exon 6 and 7 ﬂoxed, and a 300-bp product
represents the DTfam allele created by Cre-mediated re-
combination (Fig. 6B). No evidence of germline recom-
bination was found with the aP2-CreERT2 (mated before
tamoxifen induction) or Adipoq-Cre mouse lines. How-
ever, Cre-mediated excision of ﬂoxed transgene occurs in
a number of mice upon crossing with the aP2-CreBI line.
The D allele, was detectable in the tail DNA, in the absence
of any cell previously demonstrated to express aP2, and
FIG. 6. Germline deletion of ﬂoxed alleles when using the aP2-CreBI. A: Evidence of recombination of the IR locus from the aP2-CreBI in DNA from
mouse tails. DNA was extracted from tails of progeny of the aP2-CreBI mouse and mice with the ﬂoxed IR. The recombination status of the IR locus
(from left to right) are IR+/+, IRﬂ/+, IRﬂ/D, and IRﬂ/ﬂ. WT, wild-type. B: Evidence of recombination of the Tfam locus with the aP2-CreBI in DNA from
mouse tails. DNA was extracted from tails of progeny of the aP2-CreBI mouse and mice with a ﬂoxed Tfam locus. The recombination status of the
Tfam locus (from left to right) are Tfamﬂ/D and Tfam+/+. C: Frequency of the D allele is illustrated in progeny of the aP2-CreBI mouse and mice with
ﬂoxed alleles of IR, Tfam, Dicer, and Hif1b. D: Expression of IR was compared using qPCR in perigonadal fat of 3-month-old male IRﬂ/ﬂ (LOX),
aP2-CreBI IRﬂ/ﬂ (FIRKO), IRﬂ/D (DELTA), or aP2-CreBI IRﬂ/D (DELTA FIRKO) mice. Data are normalized to the expression of Tbp and are shown as
mean6 SEM of six to seven samples. E: Expression of IR was compared using qPCR in the liver of 3-month-old male animals as in panel D. Data are
normalized to the expression of Tbp and are shown as mean 6 SEM of six to seven samples. F: Expression of IR was compared using qPCR in the
brain of 3-month-old male animals as in panel D. Data are normalized to the expression of Tbp and are shown as mean 6 SEM of six to seven
samples.
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the incidence of the D allele varies across ﬂoxed trans-
genes, from as low as 1.6% in IR-ﬂoxed animals to as high
as 14.4% in Tfam-ﬂoxed animals (Fig. 6C). Furthermore,
qPCR analysis of IR mRNA from tissues of animals pos-
sessing a D IR allele, shows that the presence of the D
allele, independently of the presence of the aP2-Cre
transgene, leads to an ;60% loss of expression in peri-
gonadal fat, as well as liver and brain (Fig. 6D–F). These
results indicate that the aP2-CreBI line can lead to germline
recombination of the ﬂoxed alleles, resulting in whole-
body heterozygous knockout mice.
DISCUSSION
During the past 2 decades, advances in the use of site-
speciﬁc recombinases have added greatly to our ability to
manipulate cells and gene expression. These site-speciﬁc
recombinases bind to and recombine speciﬁc sequences of
DNA, allowing researchers to heritably label cells, condi-
tionally inactivate or activate genes, and even ablate cells
based on their gene expression. Thus far, studies exam-
ining the in vivo role of speciﬁc genes in adipocytes by
conditional ablation have largely relied on the adipose-
speciﬁc expression of the aP2 promoter (4,5), with (9,10)
or without (7,8) additional regulation by tamoxifen. Re-
cently, Adipoq-Cre lines were created as a possible alter-
native model to conditionally ablate genes in adipose
tissue (17,18). More than 70 published reports have relied
upon aP2-Cre or Adipoq-Cre lines, and although several
caveats in their use have been alluded to, thus far, these
have not been systematically assessed. In the current
study, we have performed a direct comparison and anal-
ysis of these fat-speciﬁc Cre lines.
The tissue and cell-type speciﬁcity of these different
mouse transgenic Cre lines was determined by crossing
them to the R26R-lacZ reporter mouse and analyzing the
tissues from the resultant mice for recombination. Of the
three Cre lines analyzed in this study, the Adipoq-Cre
showed the most speciﬁc expression in white and brown
fat. The aP2-CreBI R26R-lacZ mice and the aP2-CreERT2
R26R-lacZ mice also showed recombination both in brown
and white fat; however, there was nonadipose expression
with both aP2-Cre lines. This included expression in the
capillaries of the myocardium and in perivascular cells
in the skeletal muscle. On the one hand, that two inde-
pendent aP2-Cre mouse lines gave similar patterns sug-
gests that the recombination in these tissues is due to
eutopic expression of Cre recombinase directed by the aP2
promoter. On the other hand, the differences between the
aP2-CreERT2 and aP2-CreBI mice, including the staining
within the testis and salivary gland, may be due to the
different sites of transgene integration.
The large degree of recombination in the endothelial
cells of the heart observed in the aP2-CreBI and the aP2-
CreSI may explain why fat-speciﬁc Dicer-knockout animals
created with aP2-Cre exhibit perinatal lethality due to
Dicer’s known roles in vessel formation and maintenance
(39). However, such cell-type speciﬁc loss of gene ex-
pression in a tissue of mixed cell types, such as the heart
or skeletal muscle, may be difﬁcult to detect by qPCR or
Western blot because the other cells in the tissue continue
normal expression. Likewise, stochastic recombination in
the germ cell lines would be difﬁcult to detect without
histological analysis. It is also worth noting that the en-
dogenous Fabp4 expression is observed only in the small
capillaries and not in the large vessels of the heart. This
speciﬁc expression in a distinct subset of endothelial cells
suggests developmental differences between endothelial
cells. Some studies of the FIRKO mouse have observed
a reduction of IR gene expression in skeletal muscle.
However, because this reduction is only observed in the
FIRKO, this effect may be a secondary effect speciﬁc to
this line and not due to aP2-Cre deletion.
Although previous reports have shown Fabp4 expres-
sion in many other tissues, including the kidney, liver, and
skin (11), little or no recombination is observed in the aP2-
Cre lines in any of these tissues. The levels of Fabp4 are
very low in nonadipose tissue, and the lack of recom-
bination in these tissues may be due to low levels of Cre
expression that are below the threshold needed for re-
combination. Alternatively, the enhancer regions needed
for expression in these tissues may be missing from the
aP2 promoter fragment used to generate these Cre mice.
Previous reports have also shown that Fabp4 is expressed
in macrophages (40) within the heart. Here, we demon-
strate that macrophages within the adipose tissue do not
express signiﬁcant levels of Fabp4. These ﬁndings are
conﬁrmed by the absence of recombination that we ob-
serve in the macrophages of the aP2-CreBI.
In addition to differences among the Cre mice, we
demonstrate that the different ﬂoxed gene loci display
a range of sensitivity to recombination when using these
different Cre lines. With the aP2-CreBI, very efﬁcient re-
combination was observed in the Hif1b, Shox2, Glut4, and
IR loci, with far less recombination found in the combi-
nation of the IR/IGF1R double knockout loci and the
PTP1B and Tfam locus. Several factors may contribute to
this range of sensitivity to Cre-mediated recombination.
First, different ﬂoxed alleles are known to have differential
sensitivity to Cre-mediated recombination, with some loci
inherently more difﬁcult to recombine (41). Another po-
tential factor that may confound these results is that some
of the genes being inactivated may be necessary for adi-
pogenesis or survival. Work from in vitro models demon-
strates that ablation of Hif1b (28), Shox2 (unpublished
data), or Glut4 (7) does not affect adipogenesis or cellular
survival. Similarly, differentiation of preadipocytes that
lack IR can be compensated for by expression of IGF1R
(30). On the other hand, Dicer appears to be indispensible
for adipogenesis (42), and combined loss of IR and IGF1R
results in complete failure of adipocyte differentiation
(30). Although cells with a knockdown of Tfam differen-
tiate into adipocytes (43) ablation of Tfam leads to in-
creased apoptosis (44–46). Thus, in models that ablate
genes necessary for adipogenesis or cellular survival, re-
combination would appears to be less efﬁcient because the
knockout adipocytes never develop. Conversely, genes
that are expressed exclusively in the mature adipocytes,
including Glut4 (47) and Pparg (48), would have a greater
recombination efﬁciency than those expressed in multiple
cell types.
Within the FIRKO animals, we also ﬁnd that there is an
age-dependent increase in recombination efﬁciency. Sev-
eral factors may be contributing to the improved recom-
bination. First, as animals age, the cellular composition
of the fat pads may shift, including a decrease of pre-
adipocytes (49). This would lead to a relative increase in
the proportion of adipocytes compared with other cells,
and because the aP2-Cre is active in adipocytes, recom-
bination efﬁciency would appear to be improved. In ad-
dition, transcriptional activity and changes in splicing
from the IR locus have been observed during aging (50),
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suggesting that epigenetic modiﬁcations to the IR locus
occur with age. It is possible that these changes in the
IR locus may change its susceptibility to Cre-mediated
recombination.
Cre mRNA levels in the fat pads of aP2-CreBI mice are
higher than in the aP2-CreERT2 or Adipoq-Cre mice. Be-
cause the same 5.4-kb promoter fragment was used in the
creation of the aP2-CreBI and aP2-CreERT2 lines, the dif-
ference in expression between these two lines is most
likely due to differential copy number or to different sites
of transgene integration. Conversely, because only one to
two copies of a BAC transgene integrate into the genome,
the levels of Cre transgene observed in the Adipoq-Cre
mice most likely reﬂect the high endogenous expression of
Adipoq mRNA. Despite the lower Cre expression level, the
Adipoq-Cre mice demonstrate slightly greater recombi-
nation in both the subcutaneous and perigonadal fat.
These results suggest that the greater Cre expression in
the aP2-CreBI fat is due to higher expression of Cre per cell
and not to a greater number of cells expressing Cre. In
fact, the greater recombination efﬁciency observed in the
Rosa locus, as well as in the Tfam, Dicer, and PTP1B loci,
suggests that the Adipoq-Cre may direct Cre expression
to a more complete population of adipocytes than the
aP2-CreBI.
Finally, we have shown that transmission of the aP2-
CreBI can lead to germline deletion (D) of ﬂoxed alleles.
The incidence of D alleles varies across ﬂoxed transgenes
and leads to a reduction of gene expression. Strong
staining and speciﬁc LacZ staining could be seen in ;2% of
seminiferous tubules of aP2-CreBI R26R-lacZ testis, leading
to populations of recombined spermatid precursors. Be-
cause within individual mice the D allele can be indepen-
dent of the presence of Cre, recombination in the germ
cells most likely occurs early in spermatogenesis, thus
allowing Cre and D alleles to segregate during meiosis.
Although we did not observe oocytes with lacZ staining,
the D allele can also arise when the female is the carrier of
the Cre transgene, suggesting that germline recombination
may also occur in the oocyte. In our studies of using the
aP2-Cre, we excluded all animals carrying the D allele from
further analysis or breeding. However, if such mice are
not excluded from the breeding strategy, the D allele
leads to whole-body heterozygous knockouts in the next
generation. This needs to be assessed in all mice made
using Cre-Lox recombination because it can lead to
misleading phenotypes if not recognized. Although we
have not directly studied the aP2-CreSI mouse, we be-
lieve this may account for the striking difference in re-
combination speciﬁcity between original publication (8)
and the subsequent analyses (http://cre.jax.org/Fabp4/
Fabp4-creNano.html) (51), which found widespread re-
combination.
In conclusion, in this study we have analyzed the efﬁ-
cacy and speciﬁcity of transgenic Cre lines driven by the
aP2 and adiponectin gene promoters. All three lines we
examined demonstrated recombination in fat with minimal
staining in most other tissues. The aP2-Cre line demon-
strates both an allele- and age-dependent sensitivity to Cre-
mediated recombination within the fat. Finally, we show
that the aP2-Cre line can lead to germline recombination of
ﬂoxed alleles. These results are the ﬁrst systematic anal-
ysis of these Cre lines that have been widely used to study
adipocyte biology and highlight important considerations
and implications not only in their use but also in the need
for careful characterization of Cre lines in general.
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